Kestra Medical Technologies Quarterly Balance Sheet
NASDAQ: KMTSHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kestra Medical Technologies financial position
As of Jul 31, 2026, Kestra Medical Technologies reported total assets of $347.4 million, up 30.4% from a year earlier against total liabilities of $125.0 million. Shareholders' equity stood at $222.4 million, or 64.0% of assets. The company held $68.6 million in cash and equivalents against $72.5 million of debt, a net debt position of $3.9 million.
The current ratio (current assets divided by current liabilities) was 4.69, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.33.
Summary generated from market data by MetaCap's automated system. Methodology
Kestra Medical Technologies balance sheet (quarterly)
| Quarter (USD) | Q1 20262026-07-31 | Q4 20262026-04-30 | Q3 20262026-01-31 | Q2 20252025-10-31 | Q1 20252025-07-31 | Q4 20252025-04-30 | Q3 20252025-01-31 | Q2 20252024-10-31 | Q1 20252024-07-31 | Q4 20242024-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 68.56M | 99.71M | 291.32M | 175.42M | 201.21M | 237.59M | 54.35M | 76.92M | 99.97M | 8.25M |
| Short-Term Investments | 130.35M | 96.72M | — | — | — | — | — | — | — | — |
| Receivables | 15.41M | 14.54M | 12.71M | 10.41M | 9.25M | 8.08M | — | — | — | 2.00M |
| Total Current Assets | 226.27M | 222.36M | 314.06M | 195.41M | 220.69M | 255.33M | — | — | — | 14.91M |
| Property, Plant & Equipment | 63.66M | 59.09M | 53.80M | 45.93M | 40.38M | 34.83M | — | — | — | 26.11M |
| Long-Term Investments | 45.79M | 65.77M | — | — | — | — | — | — | — | — |
| Total Assets | 347.36M | 358.46M | 379.34M | 246.70M | 266.30M | 295.74M | — | — | — | 45.95M |
| Accounts Payable | 25.96M | 27.30M | 24.02M | 20.21M | 18.57M | 23.96M | — | — | — | 23.89M |
| Total Current Liabilities | 48.27M | 50.37M | 42.93M | 35.76M | 32.26M | 37.98M | — | — | — | 32.97M |
| Long-Term Debt | 72.50M | 42.65M | 42.26M | 41.87M | 41.49M | 41.10M | — | — | — | 42.54M |
| Total Liabilities | 125.00M | 98.81M | 91.35M | 82.62M | 82.14M | 90.34M | — | — | — | 78.22M |
| Shareholders' Equity | 222.36M | 259.66M | 287.99M | 164.08M | 184.16M | 205.41M | -257.89M | -236.54M | -216.47M | -209.38M |
| Retained Earnings | -695.95M | -651.86M | -613.03M | -578.86M | -546.08M | -520.25M | — | — | — | -406.44M |
| Total Debt | 72.50M | 42.65M | 42.26M | 41.87M | 41.49M | 41.10M | — | — | — | 42.54M |
| Net Cash (Debt) | 126.42M | 153.78M | 249.06M | 133.55M | 159.73M | 196.50M | 54.35M | 76.92M | 99.97M | -34.29M |
| Shares Outstanding | 59.27M | 58.38M | 58.35M | 51.45M | 51.35M | 51.35M | 100 | — | — | 105.81K |
This table shows 10 quarterly periods of Kestra Medical Technologies's balance sheet, from Q1 2026 back to Q4 2024, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow KMTS's reporting calendar. What is a balance sheet?